SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Veloxis Pharmaceuticals A/S Announces Preliminary Analysis of the STRATO Study Suggesting Reduction in Tremor in Kidney Transplant Patients Switched From Twice-Daily Tacrolimus to Once-Daily LCP-Tacro™